News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN
Photo taken from C. Jillian Tsai/X
Feb 22, 2024, 11:12

C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN

C. Jillian Tsai, Radiation Oncologist at Princess Margaret Cancer Centre, Toronto, Canada, shared a post on X/Twitter:

“CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN. (F/u of Ph2 CURB RCT The Lancet”

C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN

Read further.

Source: C. Jillian Tsai/X

C. Jillian Tsai cancer NCI CTEP Clinical Research OncoDaily Oncology The Lancet
Special Coverage
Insight
Aug 31, 2024, 17:42
Miriam Mutebi: Opportunity to coordinate Africa's biggest cancer congress and be a part of impactful change
Blog
Aug 31, 2024, 17:34
Bente Mikkelsen: A groundbreaking milestone achieved for diabetes in the WHO African Region!
Blog
Aug 31, 2024, 17:33
Sylvester Comprehensive Cancer Center's second annual APP Oncology Symposium
Blog
Aug 31, 2024, 17:31
David Muyodi Impact on Cancer Early Detection Through Community Outreach - International Cancer Institute
Blog
Aug 31, 2024, 17:28
GRACE Spanish Therapy forum don't miss the presentations from Dr. Luis Raez
Blog
Aug 31, 2024, 17:26
JC Rodriguez: Be “whole-listic”
Insight
Aug 31, 2024, 17:25
Aruni Ghose: Externally validating the Meet-URO Novel Prognostic Score in MRCC on First Line Immuno Combination Therapies
Career
Aug 31, 2024, 17:23
Stephanie Widjaja: AstraZeneca is seeking a Senior Group Director Scientist for Early Global Development
Blog
Aug 31, 2024, 17:20
Billy Rosa: Amid trauma and burnout, it 'takes courage' to reflect on mental, emotional well-being
Insight
Aug 31, 2024, 17:17
Erman Akkus: Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma
Blog
Aug 31, 2024, 17:14
TGCT in young patients and the uncertainties associated with this special population - TGCT Support
Blog
Aug 31, 2024, 17:11
Kirk Kaminsky: McKesson signed an agreement to acquire a controlling interest in Core Ventures